SE8602524L - Kinolinderivat - Google Patents

Kinolinderivat

Info

Publication number
SE8602524L
SE8602524L SE8602524A SE8602524A SE8602524L SE 8602524 L SE8602524 L SE 8602524L SE 8602524 A SE8602524 A SE 8602524A SE 8602524 A SE8602524 A SE 8602524A SE 8602524 L SE8602524 L SE 8602524L
Authority
SE
Sweden
Prior art keywords
lower alkyl
stands
general formula
image
lower alkoxy
Prior art date
Application number
SE8602524A
Other languages
English (en)
Other versions
SE466308B (sv
SE8602524D0 (sv
Inventor
E Berenyi
L Varga
L Pallos
L Petocz
L Ladanyi
P Tompe
E Hartai
A Kovacs
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of SE8602524D0 publication Critical patent/SE8602524D0/sv
Publication of SE8602524L publication Critical patent/SE8602524L/sv
Publication of SE466308B publication Critical patent/SE466308B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
SE8602524A 1985-06-04 1986-06-04 Kinolinderivat SE466308B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852193A HU195487B (en) 1985-06-04 1985-06-04 Process for producing quinoline derivatives

Publications (3)

Publication Number Publication Date
SE8602524D0 SE8602524D0 (sv) 1986-06-04
SE8602524L true SE8602524L (sv) 1986-12-05
SE466308B SE466308B (sv) 1992-01-27

Family

ID=10958222

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602524A SE466308B (sv) 1985-06-04 1986-06-04 Kinolinderivat

Country Status (28)

Country Link
US (1) US4652562A (sv)
JP (1) JPS6248668A (sv)
KR (1) KR930006775B1 (sv)
CN (1) CN1012957B (sv)
AT (1) AT392469B (sv)
AU (1) AU588883B2 (sv)
BE (1) BE904864A (sv)
CA (1) CA1266650A (sv)
CH (1) CH668069A5 (sv)
CS (1) CS257793B2 (sv)
DD (1) DD247448A5 (sv)
DE (1) DE3618724C2 (sv)
DK (1) DK162841C (sv)
ES (1) ES8707231A1 (sv)
FI (1) FI82451C (sv)
FR (1) FR2582835B1 (sv)
GB (1) GB2176185B (sv)
GR (1) GR861452B (sv)
HU (1) HU195487B (sv)
IL (1) IL79024A0 (sv)
IT (1) IT1204377B (sv)
NL (1) NL8601434A (sv)
NO (1) NO165635C (sv)
PH (1) PH24135A (sv)
PL (1) PL146498B1 (sv)
PT (1) PT82712B (sv)
SE (1) SE466308B (sv)
SU (1) SU1398773A3 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) * 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US20090117199A1 (en) * 1998-08-06 2009-05-07 Scott Timothy C Method of treatment of cancer
US8557298B2 (en) * 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
EP1320529B1 (en) * 2000-09-21 2006-05-24 Smithkline Beecham Plc Quinoline derivatives as antibacterials

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165520B (sv) * 1972-05-05 1974-09-28
IE47458B1 (en) * 1977-11-07 1984-03-21 Leo Pharm Prod Ltd Quinolylguanidine derivatives

Also Published As

Publication number Publication date
DK262186A (da) 1986-12-05
GB2176185B (en) 1988-09-28
IT1204377B (it) 1989-03-01
ES8707231A1 (es) 1987-07-16
SE466308B (sv) 1992-01-27
SU1398773A3 (ru) 1988-05-23
FR2582835B1 (fr) 1989-01-06
JPH0515705B2 (sv) 1993-03-02
CH668069A5 (de) 1988-11-30
KR870000324A (ko) 1987-02-17
NL8601434A (nl) 1987-01-02
DK162841B (da) 1991-12-16
DE3618724A1 (de) 1987-01-08
NO862230L (no) 1986-12-05
FI82451B (fi) 1990-11-30
GB2176185A (en) 1986-12-17
IT8620667A0 (it) 1986-06-04
KR930006775B1 (ko) 1993-07-23
PT82712A (en) 1986-07-01
GR861452B (en) 1986-10-03
PH24135A (en) 1990-03-05
FI82451C (sv) 1991-03-11
FI862381A (fi) 1986-12-05
CS257793B2 (en) 1988-06-15
JPS6248668A (ja) 1987-03-03
FR2582835A1 (fr) 1986-12-05
DE3618724C2 (de) 1994-06-16
FI862381A0 (fi) 1986-06-04
DD247448A5 (de) 1987-07-08
PT82712B (pt) 1988-04-21
BE904864A (fr) 1986-12-03
IL79024A0 (en) 1986-09-30
GB8613530D0 (en) 1986-07-09
US4652562A (en) 1987-03-24
DK262186D0 (da) 1986-06-04
SE8602524D0 (sv) 1986-06-04
CN1012957B (zh) 1991-06-26
AU5834486A (en) 1986-12-11
CA1266650A (en) 1990-03-13
NO862230D0 (no) 1986-06-04
HU195487B (en) 1988-05-30
HUT41008A (en) 1987-03-30
AU588883B2 (en) 1989-09-28
ES555708A0 (es) 1987-07-16
NO165635C (no) 1991-03-13
CN86103688A (zh) 1987-02-11
AT392469B (de) 1991-04-10
ATA149286A (de) 1990-09-15
NO165635B (no) 1990-12-03
PL146498B1 (en) 1989-02-28
DK162841C (da) 1992-05-04

Similar Documents

Publication Publication Date Title
ES8500241A1 (es) Procedimiento para la preparacion de derivados de imidazol
NO171785C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinazolinderivater
GR890300125T1 (en) Billiary acid derivatives, processes for the preparation thereof and phamaceutical compositions containing them
DK519985D0 (da) Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater
ATE11135T1 (de) Octahydrobenzo(f)chinolin-verbindungen.
SE8602524L (sv) Kinolinderivat
NO922729D0 (no) 2-substituerte 4,5-difenylimidazoler
ES359454A1 (es) Procedimiento de preparacion de nuevos esteres aminoalcohi-lados de acidos anilino-2 nicotinico.
DK188183D0 (da) Thiomethylpyridinderivater, fremgangsmade til deres fremstilling og laegemidler indeholdende disse forbindelser
ZA82293B (en) Phenylpiperazine derivatives of hetarylphenols and hetarylanilines,their preparation,and therapeutic agents containing these compounds
ATE30324T1 (de) Piperazin-derivate von theobromin.
PT87025A (pt) Process for the preparation of imidazol derivatives and of pharmaceutical compositions containing the same
DK412888D0 (da) Piperidin-derivater til terapeutisk anvendelse og fremgangsmaade til fremstilling deraf
ATE139441T1 (de) Verwendung von 2-iminothiazolidin-4-onderivaten als neuartige arzneimittelwirkstoffe
ATE8994T1 (de) Piperazinderivate des theophyllins.
ES8308546A1 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.
ATE79625T1 (de) Substituierte 1,3,4,9-tetrahydropyrano(3,4b>indol-1-essigs|uren.
NO158462C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2)-kondenserte 1,4-benzodiazepinforbindelser.
SE8703494D0 (sv) Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat
AR241434A1 (es) Procedimiento para la preparacion de 3-(piperidinil)-1h-indazoles.
ATE134607T1 (de) Tetrahydronaphtalenderivate, ihre herstellung und ihre therapeutische verwendung
DK434185A (da) Quinolizinonforbindelser
ATE50564T1 (de) Heterocyclische verbindungen.
GB1105679A (en) Indole derivatives

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8602524-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8602524-4

Format of ref document f/p: F